Search - tctmd.com

Displaying 321 - 340 of 743

Sort: Relevancy | Date

Patients With Schizophrenia Reap Gains From CV Meds After MI

News Daily News

Patients With Schizophrenia Reap Gains From CV Meds After MI

October 24, 2018

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

News Daily News

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

October 17, 2018

Complete Revascularization Improves Long-term NSTEMI Outcomes, Cohort Study Suggests

News Daily News

Complete Revascularization Improves Long-term NSTEMI Outcomes, Cohort Study Suggests

October 16, 2018

Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but Outcomes Unaffected

News Daily News

Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but Outcomes Unaffected

October 15, 2018

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

News Daily News

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

October 03, 2018

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

October 02, 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

September 25, 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

September 24, 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

September 22, 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

September 22, 2018

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

News Daily News

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

September 21, 2018

Readmissions High When Patients Leave Hospital Against Medical Advice After Acute MI

News Daily News

Readmissions High When Patients Leave Hospital Against Medical Advice After Acute MI

September 19, 2018

FDA Approves New Covered Stent Option for Coronary Perforations

News Daily News

FDA Approves New Covered Stent Option for Coronary Perforations

September 14, 2018

Myocardial Injury or MI? New Universal Definition Aims for Clarity

News Conference News ESC 2018

Myocardial Injury or MI? New Universal Definition Aims for Clarity

September 05, 2018

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

News Conference News ESC 2018

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

September 04, 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

News Conference News ESC 2018

Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD

August 31, 2018

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

News Conference News ESC 2018

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

August 30, 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

News Conference News ESC 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

August 29, 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

August 28, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.